RBMS1 and lung carcinoma: Recent investigations have unveiled that N-desmethyl imipramine hydrochloride (NTP) can alter RBMS1 expression in IR-resistant A549 lung cancer cells, thereby enhancing their susceptibility to radiation therapy, which opens a new therapeutic avenue for lung cancer treatment (20).